Not applicableUnknownNCT03819283What this trial is testingNASH and Coronary DiseaseWho this might be right forNon-Alcoholic Fatty Liver Disease Assistance Publique - Hôpitaux de Paris 260
Post-approval studies (Phase 4)Study completedNCT04910178What this trial is testingFollow-up of NAFLD Patients With MRI-PDFFWho this might be right forDiabetes Type 2NAFLD Asmaa Abdelfattah Elsayed 80
Post-approval studies (Phase 4)Looking for participantsNCT05644717What this trial is testingEffect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLDWho this might be right forLiver FatLiver FibrosisGlycemic Control+3 more Getz Pharma 164
Not applicableUnknownNCT04281303What this trial is testingEndoscopic Bariatric Therapy in NASH CirrhosisWho this might be right forNon-alcoholic Steatohepatitis (NASH) Instituto de Investigación Marqués de Valdecilla 10
Testing effectiveness (Phase 2)Study completedNCT05397379What this trial is testingA Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic SteatohepatitisWho this might be right forNon-Alcoholic Steatohepatitis Sunshine Lake Pharma Co., Ltd. 68
Not applicableLooking for participantsNCT07692438What this trial is testingTaiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLDWho this might be right forMetabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver Disease NAFLDDyslipidemia+1 more Taipei Medical University 60
Not applicableLooking for participantsNCT02422238What this trial is testingProspective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver DiseaseWho this might be right forNonalcoholic Fatty Liver Disease Maastricht University Medical Center 500
Testing effectiveness (Phase 2)Study completedNCT01694849What this trial is testingPhase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)Who this might be right forNon-Alcoholic Steatohepatitis (NASH) Genfit 275
Testing effectiveness (Phase 2)Study completedNCT00323414What this trial is testingPolyunsaturated Fatty Acids (PUFA) in Diabetic Fatty LiverWho this might be right forFatty Liver National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 37
Not applicableStudy completedNCT06195943What this trial is testingFeasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic SteatohepatitisWho this might be right forNASH - Nonalcoholic SteatohepatitisNASHExercise+1 more Milton S. Hershey Medical Center 17
Not applicableStudy completedNCT02985450What this trial is testingA Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in CanadaWho this might be right forNon-Alcoholic Fatty Liver DiseaseHepatitis BVaccine Reaction University of Calgary 82
Testing effectiveness (Phase 2)Study completedNCT01154985What this trial is testingDouble-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)Who this might be right forSteatohepatitis Mochida Pharmaceutical Company, Ltd. 243
Not applicableStudy completedNCT03590626What this trial is testingEffect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseWho this might be right forNon Alcoholic Fatty Liver DiseaseType2 Diabetes Mellitus Medanta, The Medicity, India 60
Large-scale testing (Phase 3)UnknownNCT05605158What this trial is testingComparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic SteatohepatitisWho this might be right forNon Alcoholic Steatohepatitis Tanta University 56
Not applicableUnknownNCT05779644What this trial is testingEffects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusWho this might be right forMetforminObesity, AbdominalDiabetes Mellitus, Type 2+4 more RenJi Hospital 300
Not applicableActive Not RecruitingNCT05256979What this trial is testingUrsodeoxycholic Acid in Patients With NAFLD - Clinical ObservationWho this might be right forNon-Alcoholic Fatty Liver Disease General University Hospital, Prague 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03468556What this trial is testingA Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic SteatohepatitisWho this might be right forNASH - Nonalcoholic Steatohepatitis Sinew Pharma Inc. 80
Not applicableUnknownNCT04543721What this trial is testing24-h-ambulatory Blood Pressure Monitoring and Pulse Wave Analysis in NAFLD PatientsWho this might be right forNAFLD; Hypertension, White-coat Hypertension, Masked Hypertension University Hospital of Cologne 200
Testing effectiveness (Phase 2)Ended earlyNCT03329885What this trial is testingExperimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious PsoriasisWho this might be right forRheumatoid ArthritisPsoriasisAnkylosing Spondylitis+2 more Bristol-Myers Squibb 38
Not applicableStudy completedNCT03738358What this trial is testingClinical Study of 12-week Trehalose Intake in Patients With Fatty Liver DiseaseWho this might be right forNon-alcoholic Fatty Liver Samsung Medical Center 39